Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Paul Franks

Paul Franks

Principal investigator

Paul Franks

Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.

Author

  • Nita G Forouhi
  • Albert Koulman
  • Stephen J Sharp
  • Fumiaki Imamura
  • Janine Kröger
  • Matthias B Schulze
  • Francesca L Crowe
  • José María Huerta
  • Marcela Guevara
  • Joline Wj Beulens
  • Geertruida J van Woudenbergh
  • Laura Wang
  • Keith Summerhill
  • Julian L Griffin
  • Edith Jm Feskens
  • Pilar Amiano
  • Heiner Boeing
  • Françoise Clavel-Chapelon
  • Laureen Dartois
  • Guy Fagherazzi
  • Paul Franks
  • Carlos Gonzalez
  • Marianne Uhre Jakobsen
  • Rudolf Kaaks
  • Timothy J Key
  • Kay-Tee Khaw
  • Tilman Kühn
  • Amalia Mattiello
  • Peter Nilsson
  • Kim Overvad
  • Valeria Pala
  • Domenico Palli
  • J Ramón Quirós
  • Olov Rolandsson
  • Nina Roswall
  • Carlotta Sacerdote
  • María-José Sánchez
  • Nadia Slimani
  • Annemieke Mw Spijkerman
  • Anne Tjonneland
  • Maria-José Tormo
  • Rosario Tumino
  • Daphne L van der A
  • Yvonne T van der Schouw
  • Claudia Langenberg
  • Elio Riboli
  • Nicholas J Wareham

Summary, in English

Conflicting evidence exists regarding the association between saturated fatty acids (SFAs) and type 2 diabetes. In this longitudinal case-cohort study, we aimed to investigate the prospective associations between objectively measured individual plasma phospholipid SFAs and incident type 2 diabetes in EPIC-InterAct participants.

Department/s

  • Genetic and Molecular Epidemiology
  • Internal Medicine - Epidemiology
  • EXODIAB: Excellence in Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health

Publishing year

2014

Language

English

Pages

810-818

Publication/Series

The Lancet Diabetes & Endocrinology

Volume

2

Issue

10

Document type

Journal article

Publisher

Elsevier

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Genetic and Molecular Epidemiology
  • Internal Medicine - Epidemiology

ISBN/ISSN/Other

  • ISSN: 2213-8595